+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Troponin Rapid Tests and Point of Care (POC) - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 38 Pages
  • December 2021
  • Region: Global
  • GlobalData
  • ID: 5517708
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

the publisher's Medical Devices sector report, “Troponin Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Troponin Rapid Tests & Point of Care (POC) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Troponin Rapid Tests & POC are point-of-care diagnostic tests enables to measure troponin levels specific to cardiovascular diseases in patient’s sample.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope


  • Extensive coverage of the Troponin Rapid Tests & Point of Care (POC) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Troponin Rapid Tests & Point of Care (POC) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy


The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Troponin Rapid Tests & Point of Care (POC) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Troponin Rapid Tests & POC Overview
3 Products under Development
3.1 Troponin Rapid Tests & POC - Pipeline Products by Stage of Development
3.2 Troponin Rapid Tests & POC - Pipeline Products by Territory
3.3 Troponin Rapid Tests & POC - Pipeline Products by Regulatory Path
3.4 Troponin Rapid Tests & POC - Pipeline Products by Estimated Approval Date
4 Troponin Rapid Tests & POC - Pipeline Products under Development by Companies
4.1 Troponin Rapid Tests & POC Companies - Pipeline Products by Stage of Development
4.2 Troponin Rapid Tests & POC - Pipeline Products by Stage of Development
5 Troponin Rapid Tests & POC Companies and Product Overview
6 Troponin Rapid Tests & POC- Recent Developments
6.1 Sep 01, 2021: BioMerieux announce First-Half 2021 Results
7 Appendix
7.1 Methodology
7.2 About The Publisher
7.3 Contact Us
7.4 Disclaimer
List of Tables
  • Troponin Rapid Tests & POC - Pipeline Products by Stage of Development
  • Troponin Rapid Tests & POC - Pipeline Products by Territory
  • Troponin Rapid Tests & POC - Pipeline Products by Regulatory Path
  • Troponin Rapid Tests & POC - Pipeline Products by Estimated Approval Date
  • Troponin Rapid Tests & POC Companies - Pipeline Products by Stage of Development
  • Troponin Rapid Tests & POC - Pipeline Products by Stage of Development
  • Glossary

List of Figures
  • Troponin Rapid Tests & POC - Pipeline Products by Stage of Development
  • Troponin Rapid Tests & POC - Pipeline Products by Territory
  • Troponin Rapid Tests & POC - Pipeline Products by Regulatory Path
  • Troponin Rapid Tests & POC - Pipeline Products by Estimated Approval Date

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Point of Care Inc
  • Angle Biosciences Inc
  • Anteo Technologies Pty Ltd
  • BBB Technologies Inc
  • Bio-AMD Inc
  • Bluejay Diagnostics Inc
  • Carclo Diagnostic Solutions Ltd
  • Group K Diagnostics
  • LumiraDx Ltd
  • MML Ltd
  • Nanomix Inc
  • Ohmx Corp
  • OPKO Health Inc
  • Proxim Diagnostics Corp
  • Resdin Technologies Inc.
  • Sandia National Laboratories
  • SpinChip Diagnostics AS